Ultrafiltration biofeedback guided by blood volume monitoring to reduce intradialytic hypotensive episodes in hemodialysis: study protocol for a randomized controlled trial

Kelvin C W Leung, Robert R Quinn, Pietro Ravani, Jennifer M MacRae, Kelvin C W Leung, Robert R Quinn, Pietro Ravani, Jennifer M MacRae

Abstract

Background: Fluid removal during dialysis, also known as ultrafiltration (UF), leads to intradialytic hypotension (IDH) in a significant number of patients treated with hemodialysis (HD) and is associated with an increase in morbidity and mortality. At present, there are no accepted standards of practice for the prevention or treatment of IDH. Relative blood volume monitoring (BVM) is based on the concept that the hematocrit increases with UF, relative to the patient's baseline hematocrit. The use of BVM biofeedback, whereby the HD machine automatically adjusts the rate of UF based on the relative blood volume, has been proposed for the prevention of IDH.

Methods/design: This is a 22-week randomized crossover trial. Participants undergo a 4-week run-in phase to standardize medications and dialysis prescriptions. Subsequently, participants are randomized to standard HD or to BVM biofeedback for a period of 8 weeks followed by a 2-week washout phase before crossing over. The dialysis prescription remains identical for both arms. The primary outcome is the frequency of symptomatic IDH as defined by an abrupt drop in the systolic blood pressure of ≥ 20 mm Hg accompanied by headache, dizziness, loss of consciousness, thirst, dyspnea, angina, muscle cramps or vomiting. Secondary outcomes include the number of symptomatic IDH episodes and any reduction in IDH episodes, nursing interventions, dialysis adequacy, total body water, extra- and intracellular fluid volumes, brain natriuretic peptide and cardiac troponin levels, blood pressure, antihypertensive medication use, patient symptoms and quality of life.

Discussion: Our study will determine the impact of using BVM biofeedback to prevent IDH and other serious adverse events in susceptible patients.

Trial registration: Clinicaltrials.gov NCT01988181 (6 November 2013).

Figures

Figure 1
Figure 1
Participant flow diagram. HD, hemodialysis; IDH, intradialytic hypotension.
Figure 2
Figure 2
Depiction of blood volume monitoring (BVM) profile and the corresponding ultrafiltration profile.

References

    1. Renal Data System US. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2012.
    1. US Renal Data System . USRDS 2011 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. MD: Bethesda; 2011. pp. 183–194.
    1. Canadian Institute for Health Information . Treatment of End-Stage Organ Failure in Canada 2001–2010. 2012.
    1. Mailloux LU, Bellucci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, Bluestone PA. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis. 1991;18:326–335. doi: 10.1016/S0272-6386(12)80091-6.
    1. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009;24:1574–1579. doi: 10.1093/ndt/gfn707.
    1. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009;119:671–679. doi: 10.1161/CIRCULATIONAHA.108.807362.
    1. Velasco N, Chamney P, Wabel P, Moissl U, Imtiaz T, Spalding E, McGregor M, Innes A, MacKay I, Patel R, Jardine A. Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients. Hemodial Int. 2012;16:465–472. doi: 10.1111/j.1542-4758.2012.00689.x.
    1. Henrich WL. Hemodynamic instability during hemodialysis. Kidney Int. 1986;30:605–612. doi: 10.1038/ki.1986.228.
    1. Tattersall J, Martin-Malo A, Pedrini L, Basci A, Canaud B, Fouque D, Haage P, Konner K, Kooman J, Pizzarelli F, Tordoir J, Vennegoor M, Wanner C, ter Wee P, Vanholder R. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant. 2007;22 Suppl 2:ii22–ii44.
    1. National Kidney Foundation K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–S153.
    1. Schreiber MJ. Setting the stage. Am J Kidney Dis. 2001;38(4 Suppl 4):S1–S10. doi: 10.1053/ajkd.2001.28089.
    1. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P. ‘U’ curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998;54:561–569. doi: 10.1046/j.1523-1755.1998.00005.x.
    1. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66:1212–1220. doi: 10.1111/j.1523-1755.2004.00812.x.
    1. Yoshimitsu T, Hirakata H, Fujii K, Kanai H, Hirakata E, Higashi H, Kubo M, Tanaka H, Shinozaki M, Katafuchi R, Yokomizo Y, Oh Y, Tomooka S, Fujimi S, Fujishima M. Cerebral ischemia as a causative mechanism for rapid progression of brain atrophy in chronic hemodialysis patients. Clin Nephrol. 2000;53:445–451.
    1. Ishida I, Hirakata H, Sugimori H, Omae T, Hirakata E, Ibayashi S, Kubo M, Fujishima M. Hemodialysis causes severe orthostatic reduction in cerebral blood flow velocity in diabetic patients. Am J Kidney Dis. 1999;34:1096–1104. doi: 10.1016/S0272-6386(99)70016-8.
    1. Breidthardt T, Burton JO, Odudu A, Eldehni MT, Jefferies HJ, McIntyre CW. Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. Clin J Am Soc Nephrol. 2012;7:1285–1292. doi: 10.2215/CJN.00460112.
    1. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4:914–920. doi: 10.2215/CJN.03900808.
    1. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol. 2009;4:1925–1931. doi: 10.2215/CJN.04470709.
    1. Selby NM, McIntyre CW. The acute cardiac effects of dialysis. Semin Dial. 2007;20:220–228. doi: 10.1111/j.1525-139X.2007.00281.x.
    1. Burton JO, Korsheed S, Grundy BJ, McIntyre CW. Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail. 2008;30:701–709. doi: 10.1080/08860220802212908.
    1. Johner C, Chamney PW, Schneditz D, Krämer M. Evaluation of an ultrasonic blood volume monitor. Nephrol Dial Transplant. 1998;13:2098–2103. doi: 10.1093/ndt/13.8.2098.
    1. Mann H, Stiller S, Schallenberg U, Thömmes A. Optimizing dialysis by variation of ultrafiltration rate and sodium concentration controlled by continuous measurement of circulating blood volume. Contrib Nephrol. 1989;74:182–190.
    1. Mancini E, Santoro A, Spongano M, Paolini F, Rossi M, Zucchelli P. Continuous on-line optical absorbance recording of blood volume changes during hemodialysis. Artif Organs. 1993;17:691–694. doi: 10.1111/j.1525-1594.1993.tb00616.x.
    1. Dasselaar JJ, Huisman RM, DE Jong PE, Franssen CFM. Relative blood volume measurements during hemodialysis: comparisons between three noninvasive devices. Hemodial Int. 2007;11:448–455. doi: 10.1111/j.1542-4758.2007.00216.x.
    1. De Vries JP, Kouw PM, van der Meer NJ, Olthof CG, Oe LP, Donker AJM, de Vries PM. Non-invasive monitoring of blood volume during hemodialysis: its relation with post-dialytic dry weight. Kidney Int. 1993;44:851–854. doi: 10.1038/ki.1993.321.
    1. Booth J, Pinney J, Davenport A. Do changes in relative blood volume monitoring correlate to hemodialysis-associated hypotension? Nephron Clin Pr. 2011;117:c179–c183. doi: 10.1159/000320196.
    1. Agarwal R, Kelley K, Light RP. Diagnostic utility of blood volume monitoring in hemodialysis patients. Am J Kidney Dis. 2008;51:242–254. doi: 10.1053/j.ajkd.2007.10.036.
    1. Sinha AD, Light RP, Agarwal R. Relative plasma volume monitoring during hemodialysis aids the assessment of dry weight. Hypertension. 2010;55:305–311. doi: 10.1161/HYPERTENSIONAHA.109.143974.
    1. Krepel HP, Nette RW, Akçahüseyin E, Weimar W, Zietse R. Variability of relative blood volume during haemodialysis. Nephrol Dial Transplant. 2000;15:673–679. doi: 10.1093/ndt/15.5.673.
    1. Steuer RR, Leypoldt JK, Cheung AK, Senekjian HO, Conis JM. Reducing symptoms during hemodialysis by continuously monitoring the hematocrit. Am J Kidney Dis. 1996;27:525–532. doi: 10.1016/S0272-6386(96)90163-8.
    1. Santoro A, Mancini E, Basile C, Amoroso L, Di Giulio S, Usberti M, Colasanti G, Verzetti G, Rocco A, Imbasciati E, Panzetta G, Bolzani R, Grandi F, Polacchini M. Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial. Kidney Int. 2002;62:1034–1045. doi: 10.1046/j.1523-1755.2002.00511.x.
    1. Ronco C, Brendolan A, Milan M, Rodeghiero MP, Zanella M, La Greca G. Impact of biofeedback-induced cardiovascular stability on hemodialysis tolerance and efficiency. Kidney Int. 2000;58:800–808. doi: 10.1046/j.1523-1755.2000.00229.x.
    1. Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, Toto RD, Stivelman J, Winchester JF, Zillman LA, Califf RM, Owen WF. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol. 2005;16:2162–2169. doi: 10.1681/ASN.2004121053.
    1. Nesrallah GE, Suri RS, Thiessen-Philbrook H, Heidenheim P, Lindsay RM. Can extracellular fluid volume expansion in hemodialysis patients be safely reduced using the hemocontrol biofeedback algorithm? A randomized trial. ASAIO J. 2008;54:270–274. doi: 10.1097/MAT.0b013e318169271e.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11:32. doi: 10.1186/1745-6215-11-32.
    1. Penne EL, Sergeyeva O. Sodium gradient: a tool to individualize dialysate sodium prescription in chronic hemodialysis patients? Blood Purif. 2011;31:86–91. doi: 10.1159/000321851.
    1. Agarwal R, Alborzi P, Satyan S, Light RP. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension. 2009;53:500–507. doi: 10.1161/HYPERTENSIONAHA.108.125674.
    1. Tai DJ, Conley J, Ravani P, Hemmelgarn BR, MacRae JM. Hemodialysis prescription education decreases intradialytic hypotension. J Nephrol. 2012;26:315–322. doi: 10.5301/jn.5000147.
    1. Schneditz D, Pogglitsch H, Horina J, Binswanger U. A blood protein monitor for the continuous measurement of blood volume changes during hemodialysis. Kidney Int. 1990;38:342–346. doi: 10.1038/ki.1990.207.
    1. Automated blood volume regulation during hemodialysis []
    1. Gabrielli D, Krystal B, Katzarski K. Improved intradialytic stability during haemodialysis with blood volume-controlled ultrafiltration. J Nephrol. 2008;c:232–240.
    1. Kuhlmann U, Goldau R, Samadi N, Graf T, Gross M, Orlandini G, Lange H. Accuracy and safety of online clearance monitoring based on conductivity variation. Nephrol Dial Transplant. 2001;16:1053–1058. doi: 10.1093/ndt/16.5.1053.
    1. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41:810–817.
    1. Chan C, McIntyre C, Smith D, Spanel P, Davies SJ. Combining near-subject absolute and relative measures of longitudinal hydration in hemodialysis. Clin J Am Soc Nephrol. 2009;4:1791–1798. doi: 10.2215/CJN.02510409.
    1. Chamney PW, Wabel P, Moissl UM, Müller MJ, Bosy-Westphal A, Korth O, Fuller NJ. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007;85:80–89.
    1. Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif. 2009;27:75–80. doi: 10.1159/000167013.
    1. Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, Taborsky P, Tetta C, Velasco N, Vlasak J, Zaluska W, Wizemann V. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008;23:2965–2971. doi: 10.1093/ndt/gfn228.
    1. Lindsay RM, Heidenheim PA, Nesrallah G, Garg AX, Suri R. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Clin J Am Soc Nephrol. 2006;1:952–959. doi: 10.2215/CJN.00040106.
    1. R Foundation for Statistical Computing. []
    1. MacRae JM, Ahmed SB, Atkar R, Hemmelgarn BR. A randomized trial comparing buttonhole with rope ladder needling in conventional hemodialysis patients. Clin J Am Soc Nephrol. 2012;7:1632–1638. doi: 10.2215/CJN.02730312.
    1. Tai DJ, Ahmed SB, Palacios-Derflingher L, Hemmelgarn BR, MacRae JM. Pneumatic compression devices during hemodialysis: a randomized crossover trial. Nephrol Dial Transplant. 2013;28:982–990. doi: 10.1093/ndt/gfs502.
    1. Program CHE. The 2013 Canadian Hypertension Education Program Recommendations. ON Canada: Markham; 2013.
    1. Reeves RA. The rational clinical examination. Does this patient have hypertension? How to measure blood pressure. JAMA. 1995;273:1211–1218. doi: 10.1001/jama.1995.03520390071036.
    1. Dasselaar JJ, Huisman RM, de Jong PE, Burgerhof JGM, Franssen CFM. Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients. ASAIO J. 2007;53:357–364. doi: 10.1097/MAT.0b013e318031b513.
    1. Nesrallah GE, Suri RS, Guyatt G, Mustafa RA, Walter SD, Lindsay RM, Akl EA. Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis. Nephrol Dial Transplant. 2013;28:182–191. doi: 10.1093/ndt/gfs389.
    1. Bégin V, Déziel C, Madore F. Biofeedback regulation of ultrafiltration and dialysate conductivity for the prevention of hypotension during hemodialysis. ASAIO J. 2002;48:312–315. doi: 10.1097/00002480-200205000-00018.
    1. Déziel C, Bouchard J, Zellweger M, Madore F. Impact of hemocontrol on hypertension, nursing interventions, and quality of life: a randomized, controlled trial. Clin J Am Soc Nephrol. 2007;2:661–668. doi: 10.2215/CJN.04171206.
    1. Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW. Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis. 2006;47:830–841. doi: 10.1053/j.ajkd.2006.01.012.
    1. Hecking M, Antlanger M, Winnicki W, Reiter T, Werzowa J, Haidinger M, Weichhart T, Polaschegg H-D, Josten P, Exner I, Lorenz-Turnheim K, Eigner M, Paul G, Klauser-Braun R, Hörl WH, Sunder-Plassmann G, Säemann MD. Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial. Trials. 2012;13:79. doi: 10.1186/1745-6215-13-79.
    1. Chan A, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet. 2013;381:91–92. doi: 10.1016/S0140-6736(12)62160-6.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj